Castle Biosciences Inc (CSTL) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Castle Biosciences Inc   (NASDAQ: CSTL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Castle Biosciences Inc Profitability Comparisons

Select each Category to receive further Information




CSTL Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q3 MRQ) 76.75 % 39.94 % 54.17 % 38.76 %
Gross Margin (Q3 TTM) 77.07 % 40.25 % 55.83 % 38.07 %
Gross Profit Margin 5 Yr. Avg. 80.12 % 41.47 % 52.73 % 32.57 %
EBITDA Margin (Q3 MRQ) 0 % 13.99 % 21.72 % 22.28 %
EBITDA Margin (Q3 TTM) 2.94 % 14.62 % 23.65 % 20.85 %
EBITDA Margin 5 Yr. Avg. 13.03 % 16.36 % 34.65 % 23.52 %
Operating Margin (Q3 MRQ) -2.65 % 8.21 % 16.59 % 16.03 %
Operating Margin (Q3 TTM) -7.43 % 8.63 % 17.93 % 16.32 %
Operating Margin 5 Yr. Avg. --27.3 % 8.63 % 14.72 % 16.67 %
Pre-Tax Profit Margin (Q3 MRQ) 0 % 6.41 % 10.94 % 13.94 %
Pre-Tax Profit Margin (Q3 TTM) -0 % 7.53 % 12.88 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. 2.6 % 7.35 % 10.64 % 12.23 %
Net Margin (Q3 MRQ) -3.98 % 5.07 % 8.14 % 11.4 %
Net Margin (Q3 TTM) -1.11 % 5.61 % 9.97 % 10.76 %
Net Margin 5 Yr. Avg. 4.81 % 5.18 % 6.12 % 9.63 %



Business Segment Profit Margin
 
Dermatologic
  Explore Dermatologic Segment  -
Non-Dermatologic
  Explore Non-Dermatologic Segment  -
Reportable
  Explore Reportable Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) 11.9 % 13.99 % 0.21 % 1.38 %
Free Cash Flow Margin (Q3 TTM) 1.05 % 9.18 % 13.96 % 9.23 %
Free Cash Flow Margin 5 Yr. Avg. - 10.66 % 15.75 % 13.81 %
Net Cash Flow Margin (Q3 MRQ) 0 % 9.5 % -0.01 % 0.15 %
Net Cash Flow Margin (Q3 TTM) -5.78 % 3.4 % 0.09 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - 1.3 % 3.09 % 5.71 %
Effective Tax Rate (Q3 MRQ)